Trademark Overview
On Monday, February 23, 2026, a trademark application was filed for RENAL DENERVATION MODULE with the United States Patent and Trademark Office. The USPTO has given the RENAL DENERVATION MODULE trademark a serial number of 99665013. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, February 23, 2026. This trademark is owned by American College of Cardiology Foundation. The RENAL DENERVATION MODULE trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:
Providing online registries featuring quality assurance measurement, performance benchmarking, utilization tracking, and outcomes assessment in the fields of medicine, healthcare, cardiovascular care, vascular care, interventional procedures, and disease management as they relate to hypertension or high blood pressure
Providing nondownloadable software for collecting, aggregating, monitoring, analyzing, reporting, benchmarking, and exporting healthcare, medical, and clinical data, including patient outcomes, procedural outcomes, treatment utilization, and medical device data, for use in quality improvement, research, regulatory reporting, and healthcare operations, all in the fields of medicine, healthcare, cardiovascular care, vascular care, interventional procedures, and disease management as they relate to hypertension or high blood pressure; providing software and software applications for real-world evidence generation and monitoring, namely, site-level, regional-level, and national-level monitoring, cohort analysis, longitudinal tracking, and comparison against benchmark datasets, all in the fields of medicine, healthcare, cardiovascular care, vascular care, interventional procedures, and disease management as they relate to hypertension or high blood pressure; providing software and software ...
